Turn Therapeutics Statistics
Total Valuation
TTRX has a market cap or net worth of $271.79 million. The enterprise value is $267.66 million.
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TTRX has 30.57 million shares outstanding. The number of shares has increased by 7.74% in one year.
| Current Share Class | 30.57M |
| Shares Outstanding | 30.57M |
| Shares Change (YoY) | +7.74% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 56.33% |
| Owned by Institutions (%) | 7.66% |
| Float | 11.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 45.86 |
| P/TBV Ratio | 58.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 1.09.
| Current Ratio | 3.19 |
| Quick Ratio | 2.98 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.18 |
Financial Efficiency
Return on equity (ROE) is -412.27% and return on invested capital (ROIC) is -92.60%.
| Return on Equity (ROE) | -412.27% |
| Return on Assets (ROA) | -56.15% |
| Return on Invested Capital (ROIC) | -92.60% |
| Return on Capital Employed (ROCE) | -72.06% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.39M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +154.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +154.00% |
| 50-Day Moving Average | 11.51 |
| 200-Day Moving Average | 7.32 |
| Relative Strength Index (RSI) | 39.87 |
| Average Volume (20 Days) | 103,529 |
Short Selling Information
The latest short interest is 530,526, so 1.74% of the outstanding shares have been sold short.
| Short Interest | 530,526 |
| Short Previous Month | 431,200 |
| Short % of Shares Out | 1.74% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 5.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.25M |
| Operating Income | -9.27M |
| Pretax Income | -12.77M |
| Net Income | -12.77M |
| EBITDA | -9.22M |
| EBIT | -9.27M |
| Earnings Per Share (EPS) | -$0.43 |
Full Income Statement Balance Sheet
The company has $10.36 million in cash and $6.23 million in debt, with a net cash position of $4.13 million or $0.14 per share.
| Cash & Cash Equivalents | 10.36M |
| Total Debt | 6.23M |
| Net Cash | 4.13M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 5.69M |
| Book Value Per Share | 0.19 |
| Working Capital | 7.60M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -5.28M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 57,818 |
| Net Borrowing | 6.72M |
| Free Cash Flow | -5.28M |
| FCF Per Share | -$0.17 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TTRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.74% |
| Shareholder Yield | -7.74% |
| Earnings Yield | -4.88% |
| FCF Yield | -1.88% |
Analyst Forecast
The average price target for TTRX is $25.00, which is 181.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 181.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |